ENX-101
ENX-101 is an orally active (GABAA) receptor partial positive allosteric modulator (PAM) . ENX-101 is selective to α2β2γ2L (EC50 = 0.76 nM), α2β3γ2L (EC50 = 0.61 nM), α3 (EC50 = 1.97 nM), α5 (EC50 = 0.85 nM) subunits of GABA receptor. ENX-101 possesses antiseizure activity in several animal models[1].
Product Specifications
UNSPSC
12352005
Target
GABA Receptor
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Smiles
FC1=CC=C(F)C=C1C2=NN=C3N2N=C(OCC4=NC=NN4C)C(C(C([2H])([2H])[2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])=C3.O
Molecular Formula
C19H12D9F2N7O2
Molecular Weight
426.47
References & Citations
[1]Serrats J, et al., ENX-101, a GABAA receptor α2,3,5-selective positive allosteric modulator, displays antiseizure effects in rodent seizure and epilepsy models. Epilepsia. 2025 Mar 15.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
Phase 2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K3672704 1.0 µg DNA
Myct1 sgRNA CRISPR Lentivector (Mouse) (Target 3)
Sign In for Pricing
View Details MBS6471693-01 0.2 mL
CYP26A1, ID (Cytochrome P450, Family 26, Subfamily A, Polypeptide 1, Cytochrome P450, 26A1, Retinoic Acid-metabolizing Cytochrome, Cytochrome P450 Retinoic Acid-Inactivating 1, Cytochrome P450RAI, hP450RAI, Retinoic Acid 4-hydroxylase, CYP26, P450RAI1) (F
Sign In for Pricing
View Details MBS6471693-02 5x 0.2 mL
CYP26A1, ID (Cytochrome P450, Family 26, Subfamily A, Polypeptide 1, Cytochrome P450, 26A1, Retinoic Acid-metabolizing Cytochrome, Cytochrome P450 Retinoic Acid-Inactivating 1, Cytochrome P450RAI, hP450RAI, Retinoic Acid 4-hydroxylase, CYP26, P450RAI1) (F
Sign In for Pricing
View Details 